| Product NDC: | 50236-001 |
| Proprietary Name: | Visudyne |
| Non Proprietary Name: | verteporfin for injection |
| Active Ingredient(s): | 15 mg/1 & nbsp; verteporfin for injection |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 50236-001 |
| Labeler Name: | QLT Ophthalmics, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021119 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20000412 |
| Package NDC: | 50236-001-15 |
| Package Description: | 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 CARTON (50236-001-15) |
| NDC Code | 50236-001-15 |
| Proprietary Name | Visudyne |
| Package Description | 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 CARTON (50236-001-15) |
| Product NDC | 50236-001 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | verteporfin for injection |
| Dosage Form Name | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20000412 |
| Marketing Category Name | NDA |
| Labeler Name | QLT Ophthalmics, Inc. |
| Substance Name | VERTEPORFIN |
| Strength Number | 15 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Photoabsorption [MoA],Photoenhancer [EPC],Photosensitizing Activity [PE] |